As of 3:59pm ET
| +0.18 / +5.83%|
The 2 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 126.00, with a high estimate of 126.00 and a low estimate of 126.00. The median estimate represents a +3,753.21% increase from the last price of 3.27.
The current consensus among 2 polled investment analysts is to Buy stock in First Wave BioPharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.